Autolus reports Q1 2024 Financial Results | Company Announcement
Investegate announcements from Autolus reports Q1 2024 Financial Results
Stay updated with breaking news from Market Authorization Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Autolus reports Q1 2024 Financial Results
First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HBV functional cure First of several studies to investigate the potential of BRII-179 in...
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as...
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.